SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-006360
Filing Date
2020-05-05
Accepted
2020-05-05 08:19:13
Documents
17
Period of Report
2020-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K earningsrelease8-k3x31.htm   iXBRL 8-K 60807
2 EXHIBIT 99.1 - 3.31.20 EARNINGS RELEASE ex991earningsreleaseq1.htm EX-99.1 130862
8 vericellogoa26.jpg GRAPHIC 48734
  Complete submission text file 0001628280-20-006360.txt   420931

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20200331.xsd EX-101.SCH 5052
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20200331_cal.xml EX-101.CAL 867
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20200331_def.xml EX-101.DEF 1716
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20200331_lab.xml EX-101.LAB 26457
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20200331_pre.xml EX-101.PRE 14102
13 EXTRACTED XBRL INSTANCE DOCUMENT earningsrelease8-k3x31_htm.xml XML 4158
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 20846918
SIC: 2836 Biological Products, (No Diagnostic Substances)